Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy

被引：0
|
作者：
P Österlund
L-M Soveri
H Isoniemi
T Poussa
T Alanko
P Bono
机构：
[1] Helsinki University Central Hospital,Department of Oncology
[2] P.O. Box 180,Department of Surgery
[3] HUS Helsinki 00029,undefined
[4] Finland,undefined
[5] Helsinki University Central Hospital,undefined
[6] STAT-consulting,undefined
[7] Laboratory of Molecular Oncology,undefined
[8] Molecular Cancer Biology Research Program,undefined
[9] University of Helsinki,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
bevacizumab; hypertension; predictive factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：599 / 604
页数：5
相关论文
共 50 条
  • [1] Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
    Oesterlund, P.
    Soveri, L. -M
    Isoniemi, H.
    Poussa, T.
    Alanko, T.
    Bono, P.
    BRITISH JOURNAL OF CANCER, 2011, 104 (04) : 599 - 604
  • [2] BEVACIZUMAB-CONTAINING CHEMOTHERAPY IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER
    Jernej, Benedik
    Marko, Boc
    Zvezdana, Hlebanja
    Neva, Volk
    Martina, Rebersek
    Janja, Ocvirk
    Tanja, Mesti
    ANNALS OF ONCOLOGY, 2014, 25
  • [3] Effect and safety of bevacizumab-containing chemotherapy treatment in Chinese patients with metastatic colorectal cancer
    Wu, Qian
    Shi, Yan
    Chen, Li
    Xiao, Xiaoyi
    Dai, Guanghai
    ONCOTARGETS AND THERAPY, 2013, 6 : 485 - 490
  • [4] Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy
    Wang, Zhiming
    Liang, Li
    Yu, Yiyi
    Wang, Yan
    Zhuang, Rongyuan
    Chen, Yong
    Cui, Yuehong
    Zhou, Yuhong
    Liu, Tianshu
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 39 (03) : 1239 - 1246
  • [5] Lactate Dehydrogenase Is a Useful Marker for Predicting the Efficacy of Bevacizumab-containing Chemotherapy in Patients With Metastatic Colorectal Cancer
    Shibutani, Masatsune
    Maeda, Kiyoshi
    Kashiwagi, Shinichiro
    Nagahara, Hisashi
    Fukuoka, Tatsunari
    Iseki, Yasuhito
    Wang, En
    Okazaki, Yuki
    Hirakawa, Kosei
    Ohira, Masaichi
    ANTICANCER RESEARCH, 2021, 41 (07) : 3535 - 3542
  • [6] Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?
    Grothey, A
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (01): : 22 - 23
  • [7] Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?
    Axel Grothey
    Nature Clinical Practice Oncology, 2006, 3 : 22 - 23
  • [8] Bevacizumab-containing Chemotherapy is Safe in Patients with Unresectable Metastatic Colorectal Cancer and a Synchronous Asymptomatic Primary Tumor
    Cetin, Bulent
    Kaplan, Mehmet Ali
    Berk, Veli
    Tufan, Gulnihal
    Benekli, Mustafa
    Isikdogan, Abdurrahman
    Ozkan, Metin
    Coskun, Ugur
    Buyukberber, Suleyman
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (01) : 28 - 32
  • [9] Analysis of Adverse Events of Bevacizumab-containing Systemic Chemotherapy for Metastatic Colorectal Cancer in Japan
    Isobe, Taichi
    Uchino, Keita
    Makiyama, Chinatsu
    Ariyama, Hiroshi
    Arita, Shuji
    Tamura, Shingo
    Komoda, Masato
    Kusaba, Hitoshi
    Shirakawa, Tsuyoshi
    Esaki, Taito
    Mitsugi, Kenji
    Takaishi, Shigeo
    Akashi, Koichi
    Baba, Eishi
    ANTICANCER RESEARCH, 2014, 34 (04) : 2035 - 2040
  • [10] A prognostic model for overall survival in recurrent glioma patients treated with bevacizumab-containing therapy
    Jin, Shanmu
    Chen, Wenlin
    Guo, Xiaopeng
    Xing, Hao
    Yang, Huiyu
    Liu, Qianshu
    Liu, Delin
    Zhang, Kun
    Wang, Hai
    Xia, Yu
    Guo, Siying
    Wang, Yaning
    Shi, Yixin
    Li, Yilin
    Wang, Yuekun
    Li, Junlin
    Wu, Jiaming
    Liang, Tingyu
    Qu, Tian
    Li, Huanzhang
    Yang, Tianrui
    Wang, Yu
    Ma, Wenbin
    DISCOVER ONCOLOGY, 2024, 15 (01)
12345